Atlas Trials

Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies

Clinical trial NCT07534007 · RECRUITING

Trial details

NCT number
NCT07534007
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
RECRUITING
Study type
OBSERVATIONAL
RZV Vaccine (Shingrix ®)
Start date
2026-02-24
Primary completion
2027-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.